title: Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
authors.affiliation: Cairo University Hospital, Cairo, Egypt; St. Peter's Andrology Centre, Institute of Urology, London, UK.
authors.forename: Amr
authors.initials: A
authors.lastname: Abdel Raheem
authors.forename: David
authors.initials: D
authors.lastname: Ralph
mesh_terms: D047009:Hathewaya histolytica / Q000201:enzymology*; D006801:Humans; D008297:Male; D003012:Microbial Collagenase / Q000008:administration & dosage*; D010411:Penile Induration / Q000188:drug therapy*
chemical_list: D003012:Microbial Collagenase